QuickView for CD4-positive, alpha-beta T cell cytokine production (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
2. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
3. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
4. Bone marrow-derived macrophage gene expression after T. whipplei or E. coli LPS stimulation
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for CD4-positive, alpha-beta T cell cytokine production

1. Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.
2. Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Ce…
3. Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Ado…
4. Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation
5. Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS